Healthcare Bizdev
HCBD-Pro Services Client Subscribers

HCBD-PRO Services

Query News -

Welcome <Guest> Login
Boehringer Ingelheim Pharmaceuticals Inc.
 
[900 Ridgebury Rd]
PO Box 368
Ridgefield , CT   06877-1058   USA
203-798-9988
 
Company Website:
http://us.boehringer-ingelheim.com/
Newsroom
Contact the Company

 
Business Focus:
Pharmaceutical
Company Description:
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation (Ridgefield, CT) and a member of the Boehringer Ingelheim group of companies.
 
Company Ownership:
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

Company Contacts:
Media Contact(s)
Marybeth C. McGuire
[Corporate Media Manager]
 
Kate O'Connor
[Executive Director, Public Relations]
 
Chris Wahlers
[Associate Director of Communications]
 
Susan Holz
[Manager]
 
Anna Moses
[Communications & Public Relations Manager]
 

Company Officials:
J. Martin Carroll
[President & CEO]
 
Alessandro Banchi
[Chairman of the Board of Managing Directors]
 
Eric Uderitz
[Director - Payor Solutions]
 
Heather Montanaro
[Manager, Managed Markets Marketing]
 
Michael Rausch
[Area Director - Managed Markets]
 
Kamy Missaghi
[Chief Information Officer]
 
Anne Burke
[Executive Director, Benefits]
 
Christine Marsh
[Senior Vice President - Market Access]
 
James E. Wood
[National Account Director of Managed Markets Marketing, State, Federal, and LTC]
 
View Additional Employees and Representatives
View Past Employees/Others with Past Affiliations

Company News/Coverage:
Jardiance associated with a total cost of care savings of more than 20%, according to results from an outcomes-based agreement between Boehringer Ingelheim and Highmark
Highmark, Boehringer Ingelheim Announce Value-Based Contract for COPD Medication Stiolto Respimat
Inovalon Announces Agreement With Boehringer Ingelheim to Support Outcome-Based Contracting
Healthrageous, United BioSource And Boehringer Ingelheim Launch SMART Digital Diabetes Study
Boehringer Ingelheim Cares Foundation Launches New Patient Assistance Program Portal
View all remaining Company News/Coverage headlines
About Us | Purchase Pro | Contact Us

© 2006-2010 Healthcare BizDev, Inc. All rights reserved. Privacy Policy | Legal Conditions